CTOR

Citius Oncology
CTOR

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $62.6M invested in Citius Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.87M
2
+$2.42M
3
+$549K
4
CAC
Cowen and Company
New York
+$304K
5
PC
Periscope Capital
Ontario, Canada
+$82.1K

Top Sellers

1
-$774K
2
-$460K
3
-$325K
4
WAM
Wolverine Asset Management
Illinois
-$120K
5
CH
CVI Holdings
Delaware
-$21.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.1M
2
$5.82M
3
$5.38M
4
$5.22M
5
$4.43M
6
$4.31M
7
$3.77M
8
$3.68M
9
$3.5M
10
$3.22M
11
$2.87M
12
$2.44M
13
$2.42M
14
$1.92M
15
$1.62M
16
$1.52M
17
$1.45M
18
$1.3M
19
$808K
20
$423K
21
$304K
22
$130K
23
$862
24
–
25
–